US Patent 9433371 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Otsuka Chemical Co Ltd

Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

Contact Supplier

Evonik Health Care is the innovation hub for leading life science companies

Contact Supplier

Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

Contact Supplier

Axplora is your partner of choice for complex APIs.

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

pharmacompass-2-2026-02-09

Otsuka Chemical Co Ltd

VIRTUAL BOOTH, Contact Details

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 36 News #PharmaBuzz

Interview #SpeakPharma
Vlog #PharmaReel
Data Compilation #PharmaFlow
36 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

16 All APIs, 16 USDMF, 1 JDMF, 1 NDC API

16 All APIs
16 USDMF
1 JDMF
1 NDC API

FINISHED DOSAGE FORMULATIONS

46 FDF Dossiers, 41 FDA Orange Book, 5 Europe

46 FDF Dossiers
41 FDA Orange Book
5 Europe

SERVICES

API Manufacturing, API & Drug Product Development

API Manufacturing
- 1 Oligonucleotide / Polynucleotide
API & Drug Product Development
- 1 API Development

INSPECTIONS & REGISTRATIONS

3 FDA

3 FDA

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

6 All

01 6OTSUKA

filter Patent Number Reset all filters

6 All

01 69433371

API Patent Reset all filters

6 All

01 6Blank

filter FDF Patent Reset all filters

6 All

01 6Y

filter Expiration Date Reset all filters

6 All

01 62029-09-15

01

OTSUKA

BePharma

Not Confirmed

OTSUKA

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-09-15

ARIPIPRAZOLE

US Patent Number : 9433371

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 207202

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-09-15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

OTSUKA

BePharma

Not Confirmed

OTSUKA

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-09-15

ARIPIPRAZOLE

US Patent Number : 9433371

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 207202

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-09-15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

OTSUKA

BePharma

Not Confirmed

OTSUKA

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-09-15

ARIPIPRAZOLE

US Patent Number : 9433371

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 207202

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-09-15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

OTSUKA

BePharma

Not Confirmed

OTSUKA

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-09-15

ARIPIPRAZOLE

US Patent Number : 9433371

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 207202

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-09-15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

OTSUKA

BePharma

Not Confirmed

OTSUKA

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-09-15

ARIPIPRAZOLE

US Patent Number : 9433371

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 207202

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-09-15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

OTSUKA

BePharma

Not Confirmed

OTSUKA

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-09-15

ARIPIPRAZOLE

US Patent Number : 9433371

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 207202

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-09-15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.